Skip to main content

Table 1 Demographic characteristics of the study population (n = 377)

From: Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease

Characteristics

Mean ± SD

Age, years

73.0 ± 10.1

Male sex, n (%)

371 (98.4 %)

BMI, (kg/m2)

23.6 ± 3.0

Smoking history

 Never smoker, n (%)

22 (6.0 %)

 Ex-smoker, n (%)

232 (63.0 %)

 Current smoker, n (%)

114 (31 %)

FEV1, L

1.4 ± 0.5

FEV1, predicted %

59.8 ± 23.0

Exacerbation in previous year, times

0.6 ± 1.2

Comorbidities

 Cardiovascular disease, n (%)

157 (41.6 %)

 Ischemic heart disease, n (%)

35 (9.3 %)

 Heart failure, n (%)

15 (4.0 %)

 Hypertension, n (%)

129 (34.2 %)

 Arrhythmia, n (%)

19 (5.0 %)

 Depression, n (%)

10 (2.7 %)

Maintenance inhaler

 LABA, n (%)

18 (4.8 %)

 LAMA, n (%)

87 (23.1 %)

 LABA/LAMA, n (%)

21 (5.6 %)

 LABA/ICS, n (%)

72 (19.1 %)

 LAMA/ICS, n (%)

3 (0.8 %)

 LABA/LAMA/ICS, n (%)

90 (23.9 %)

 No maintenance inhaler, n (%)

86 (22.8 %)

GOLD classification

 Group A, n (%)

60 (15.9 %)

 Group B, n (%)

150 (39.8 %)

 Group C, n (%)

34 (9.0 %)

 Group D, n (%)

133 (35.3 %)

PSQI score

 PSQI >5, n (%)

200 (53.1 %)

 PSQI5, n (%)

177 (46.9 %)

  1. Abbreviations: BMI body mass index, GOLD Global Initiative for Chronic Obstructive Lung Disease, FEV 1 forced expiratory volume in the first second, FVC forced vital capacity, ICS inhaled corticosteroids, LABA long-acting beta agonists, LAMA long-acting muscarinic antagonist, PSQI Pittsburgh sleep quality index